GlassScriptPhysician profile
Dilan Kim Ipek
NPI 1952188633
$1,915.82
in general payments reported to CMS, 2019-2025
18 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $381 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,821 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,820.83 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $359.43 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Abbvie INC. | $358.65 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $211.83 | 2024-2025 | Dupixent |
| Amgen INC. | $202.32 | 2025 | Otezla |
| Ucb, INC. | $168.94 | 2024-2025 | Bimzelx |
| Mayne Pharma Commercial LLC | $166.77 | 2025 | |
| Revance Therapeutics, INC. | $147.73 | 2025 | Daxi |
| Lilly USA, LLC | $42.56 | 2024 | Ebglyss, Taltz |
| Incyte Corporation | $42.17 | 2024-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $34.38 | 2025 | Sotyktu |
| Genzyme Corporation | $29.90 | 2024 | |
| Organon LLC | $25.99 | 2025 | |
| Almirall LLC | $25.80 | 2025 | Seysara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.65 | 2024 | Spevigo |
| Sun Pharmaceutical Industries INC. | $21.52 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $20.15 | 2025 | Sofdra |
| Leo Pharma INC. | $16.78 | 2024 | Adbry |
| Lnhc, INC | $15.25 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilan Ipek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.